COVID 19 therapies and anti-cancer drugs: A systematic review of recent literature
Review article
[키워드] ACE2angiotensin-converting enzyme 2
AIFAItalian Medicines Agency (Agenzia Italiana del Farmaco)
androgen receptor signaling inhibitors
angiotensin-converting enzyme 2
antineoplastic drugs
ARSIandrogen receptor signaling inhibitors
article
Cancer
cancer patient
checkpoint inhibitors
Chemotherapy
Clinical practice
clinical trial
Colchicine
conducted
Corona Virus Disease
Course
COVID
COVID 19
COVID-19
COVID-19 pandemic
COVID-19corona virus disease
CPIcheckpoint inhibitors
CYPcytochrome P450
cytochrome P450
Dipeptidyl peptidase 4
disease
disease-modifying antirheumatic drugs
DMARDsdisease-modifying antirheumatic drugs
DPP4Dipeptidyl peptidase 4
drug
drug interaction
Future
highlight
HIV-1human immunodeficiency virus
Human immunodeficiency virus
IL6Interleukin 6
Immunotherapy
Inconclusive
Interaction
interleukin 6
Italian Medicines Agency (Agenzia Italiana del Farmaco)
literature review
oncologist
positive
provide
Result
ruxolitinib
systematic review
targeted therapy
therapy
Tocilizumab
Treatment
treatments for COVID-19
[DOI] 10.1016/j.critrevonc.2020.102991 [Article Type] Review article
[DOI] 10.1016/j.critrevonc.2020.102991 [Article Type] Review article